Avstera Therapeutics Closes Seed Round To Advance Its Lead Programs Targeting Solid Tumors
Round Type
Seed
MalvernBiotechnologyHealthcareDescription
Avstera Therapeutics Corp., a biotechnology company based in the Philadelphia area, has announced the completion of its seed round to advance its lead cancer programs geared towards targeting solid tumors. The company intends to use proceeds to enable its lead highly specific HDAC6i for IND filing targeting locally advanced and metastatic solid tumors by the end of next year.
Quick answer
Avstera Therapeutics raised an undisclosed amount in a Seed round, dated November 9, 2022. Avstera Therapeutics is based in Malvern, Pennsylvania, United States.
- How much did Avstera Therapeutics raise?
- Avstera Therapeutics raised an undisclosed amount in a Seed round on November 9, 2022.
- What does Avstera Therapeutics do?
- Specialty oncology-focused biopharmaceutical company with a broad pipeline encompassing novel small molecules and biologics with a focus on foundational tumor biology science, while methodologically breaking barriers..
- Where is Avstera Therapeutics based and how big is it?
- Avstera Therapeutics is based in Malvern, Pennsylvania, United States.
- Who are the decision-makers at Avstera Therapeutics?
- Fundz holds 1 contact at Avstera Therapeutics, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Avstera Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Streamex Corp. raised $1.1M (Seed) on December 21, 2022.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- QurAlis raised $60M on December 20, 2022.
- Cabinet Health raised $17M (Funding Round) on December 15, 2022.
- BehaVR raised an undisclosed amount (Series B) on December 13, 2022.
- Tellus Therapeutics raised $35M (Series A) on December 13, 2022.
Who to call at Avstera Therapeutics, and when
A new round usually means Avstera Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Avstera Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avstera Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avstera Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avstera Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Avstera Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.